Annual report [Section 13 and 15(d), not S-K Item 405]

Cover Page

v3.25.2
Cover Page - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
May 31, 2025
May 31, 2024
Jun. 30, 2025
Nov. 30, 2024
Cover [Abstract]        
Document Type 10-K      
Document Annual Report true      
Document Period End Date May 31, 2025      
Document Transition Report false      
Securities Act File Number 000-49908      
Entity Registrant Name CytoDyn Inc.      
Entity Incorporation, State or Country Code DE      
Entity Tax Identification Number 83-1887078      
Entity Address, Address Line One 1111 Main Street, Suite 660      
Entity Address, City or Town Vancouver      
Entity Address, State or Province WA      
Entity Address, Postal Zip Code 98660      
City Area Code 360      
Local Phone Number 980-8524      
No Trading Symbol Flag true      
Title of 12(g) Security Common Stock, par value $0.001 per share      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] false      
Entity Shell Company false      
Entity Public Float       $ 134,520
Entity Common Stock, Shares Outstanding     1,251,534  
Auditor Name CBIZ CPAs P.C. Marcum llp    
Auditor Firm ID 199 688    
Auditor Location Hartford, CT Hartford, CT    
Entity Central Index Key 0001175680      
Current Fiscal Year End Date --05-31      
Document Fiscal Year Focus 2025      
Document Fiscal Period Focus FY      
Amendment Flag false      
Documents Incorporated by Reference [Text Block]

Document

   

Parts Into Which Incorporated

Portions of the Proxy Statement for the 2025 Annual Meeting of Stockholders

Part III